5 citations · 6 across the 3 of their papers we have counts for
3 papers
A Reflection on the Impact of Misspecifying Unidentifiable Causal Inference Models in Surrogate Endpoint Evaluation
Gokce Deliorman, Florian Stijven, Wim Van der Elst +2
Surrogate endpoints are often used in place of expensive, delayed, or rare true endpoints in clinical trials. However, regulatory authorities require thorough evaluation to accept…
Identifying predictive biomarkers of CIMAvaxEGF success in advanced Lung Cancer Patients
Patricia Luaces, Lizet Sanchez, Danay Saavedra +5
Objectives: To identify predictive biomarkers of CIMAvaxEGF success in the treatment of Non-Small Cell Lung Cancer Patients. Methods: Data from a clinical trial evaluating the effe…
A permutational-splitting sample procedure to quantify expert opinion on clusters of chemical compounds using high-dimensional data
Elasma Milanzi, Ariel Alonso, Christophe Buyck +2
Expert opinion plays an important role when selecting promising clusters of chemical compounds in the drug discovery process. We propose a method to quantify these qualitative asse…